This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Medknow Publications | |
|---|---|
| Name | Medknow Publications |
| Founded | 1997 |
| Founder | Bangalore‑based entrepreneurs |
| Country | India |
| Headquarters | Mumbai |
| Publications | Academic journals |
| Topics | Medicine, health sciences |
Medknow Publications is an Indian publishing house focused on scholarly journals in the biomedical and allied health sciences. Founded in the late 1990s, it gained prominence for publishing peer‑reviewed periodicals and facilitating dissemination for professional societies. The company developed services spanning editorial management, production, and distribution for associations, societies, and institutions.
The company emerged during a period when scholarly communication in India and South Asia sought alternatives to established Western presses, paralleling developments seen at Elsevier, Springer, Wiley, and Taylor & Francis. Early expansion involved collaborations with regional learned societies such as the Indian Medical Association, Association of Physicians of India, and specialty groups linked to institutions like All India Institute of Medical Sciences and Christian Medical College Vellore. During the 2000s it navigated the shifting landscape of digital publishing alongside platforms like PubMed Central, HighWire Press, and initiatives tied to National Institutes of Health. Leadership engaged with forums including the International Committee of Medical Journal Editors and conferences such as the World Congress on Medical and Health Informatics to align practices with global standards. The publisher’s trajectory intersected with the rise of open access movements exemplified by Budapest Open Access Initiative and policy debates in jurisdictions including United Kingdom and United States.
Medknow offered turnkey journal services comparable to those from Oxford University Press, Cambridge University Press, SAGE Publications, and BMJ Group. Services included manuscript handling systems akin to Editorial Manager, typesetting workflows resembling those of InDesign users in large houses like Nature Publishing Group, and hosting infrastructures paralleling ScholarOne. Revenue streams combined society contracts, print subscriptions, advertising from pharmaceutical firms such as GlaxoSmithKline, Novartis, and Pfizer, and article processing charges resembling models used by PLOS, BioMed Central, and Frontiers. The firm provided indexing support to assist journals in gaining inclusion in databases like Index Medicus, Scopus, Web of Science, and Embase. Editorial support involved liaison with editors affiliated with universities such as University of Mumbai, University of Delhi, University of Oxford, and Harvard University.
The publisher amassed a portfolio of clinical and specialty journals covering fields that intersect with organizations like Cardiological Society of India, Indian Psychiatric Society, Indian Orthopaedic Association, and societies connected to hospitals such as Tata Memorial Hospital and KEM Hospital. Subject areas ranged from dermatology and ophthalmology to toxicology and pharmacology, with titles pursuing indexing by services including PubMed, CrossRef, DOAJ, and MEDLINE. Collaborations extended to editorial boards containing contributors from institutions such as Johns Hopkins University, Mayo Clinic, Royal College of Surgeons, and World Health Organization panels. The output often mirrored thematic concerns addressed at congresses like the World Congress of Cardiology and International Conference on Medical Education.
The publisher embraced open access approaches similar to those promoted by SPARC and legal frameworks referenced in policy debates within European Union and India about publicly funded research access. Open access practices were influenced by models from PLOS, BioMed Central, and repository strategies paralleling arXiv and PubMed Central. This orientation affected relationships with funding agencies such as the Wellcome Trust, National Institutes of Health, and national research councils in India and Australia. The company’s approach aligned with citation‑visibility goals seen in analyses by groups like Committee on Publication Ethics and indexing initiatives such as Directory of Open Access Journals.
The publisher contributed to increased visibility for regionally produced scholarship, affecting citation flows tracked by Scopus and Web of Science and influencing metrics discussed in forums including the Research Excellence Framework and debates about impact factor from Clarivate Analytics. Critiques mirrored concerns raised across the industry regarding peer review standards and editorial independence discussed by entities like COPE and commentators in The Lancet and BMJ. Some commentators compared practices to those scrutinized in cases involving commercial publishers such as OMICS Publishing Group and debated quality control in the context of predatory publishing literature by scholars at University of Illinois and Cornell University.
The company became part of strategic consolidation trends similar to acquisitions by Springer Nature and corporate arrangements reminiscent of deals between Wolters Kluwer and regional imprints. Partnerships included technology and distribution agreements with platform providers like EBSCO, ProQuest, and aggregator services used by libraries at University of Cambridge, University of California, and Indian Institute of Science. The acquisition landscape placed the publisher among peers involved in mergers and acquisitions analyzed by firms such as McKinsey & Company and reported in trade outlets like Publishers Weekly and The Bookseller.
Category:Academic publishing companies